Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo.
暂无分享,去创建一个
Kerong Dai | Chao Zhang | Xiaoling Zhang | K. Dai | Chang-long Yu | Tingting Tang | Changlong Yu | Xiaoling Zhang | Xushi | Chao Zhang | Ting‐ting Tang
[1] Ronald G. Crystal,et al. The gene as the drug , 1995, Nature Medicine.
[2] Antonios G Mikos,et al. Advances in drug delivery for articular cartilage. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[3] M. Sheppard,et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. , 1999, The American journal of pathology.
[4] L. Seymour,et al. Key issues in non-viral gene delivery: Adv Drug Deliv Rev , 1998 .
[5] A. Rolland,et al. Target Specific Optimization of Cationic Lipid-Based Systems for Pulmonary Gene Therapy , 1998, Pharmaceutical Research.
[6] R. Mumper,et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[7] D. Zukor,et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. , 2005, Arthritis and rheumatism.
[8] J. Bonadio,et al. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. , 1995, The Journal of clinical investigation.
[9] A. Chan,et al. Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. , 2003, Biochimica et biophysica acta.
[10] J. Pelletier,et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. , 1997, Arthritis and rheumatism.
[11] Y. Hirasawa,et al. Adenovirus mediated gene delivery to the joints of guinea pigs. , 1998, The Journal of rheumatology.
[12] L. Seymour,et al. Key issues in non-viral gene delivery. , 1998, Advanced drug delivery reviews.
[13] J. Pelletier,et al. Cytokines and their role in the pathophysiology of osteoarthritis. , 1999, Frontiers in bioscience : a journal and virtual library.
[14] U. Bakowsky,et al. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. , 2004, Journal of nanoscience and nanotechnology.
[15] C. McIlwraith,et al. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene , 2002, Gene Therapy.
[16] Y. Okahata,et al. Mechanism of cell transfection with plasmid/chitosan complexes. , 2001, Biochimica et biophysica acta.
[17] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[18] J. Saklatvala. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage , 1986, Nature.
[19] R. Mumper,et al. Novel polymeric condensing carriers for gene delivery , 1995 .
[20] Y. Machida,et al. Biodegradation and distribution of water-soluble chitosan in mice. , 1999, Biomaterials.
[21] Lisbeth Illum,et al. Chitosan as a Novel Nasal Delivery System for Peptide Drugs , 1994, Pharmaceutical Research.
[22] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[23] T. Bettinger,et al. Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.
[24] M. Takigawa,et al. Direct adenovirus-mediated gene delivery to the temporomandibular joint in guinea-pigs. , 1999, Archives of oral biology.
[25] J. Lowe,et al. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. , 1997, Journal of pharmaceutical sciences.
[26] James M. Wilson,et al. Methods of gene delivery. , 1998, Hematology/oncology clinics of North America.
[27] J. Haskill,et al. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats. , 1995, Gene therapy.
[28] C. P. Sharma,et al. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. , 1997, Journal of biomedical materials research.
[29] I. Verma,et al. Gene therapy - promises, problems and prospects , 1997, Nature.
[30] K. Leong,et al. DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[31] R. Gay,et al. Gene therapy in osteoarthritis. , 2000, Joint, bone, spine : revue du rhumatisme.
[32] E. Terwilliger,et al. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. , 2003, Human gene therapy.
[33] R. Lockey,et al. Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. , 2004, Journal of nanoscience and nanotechnology.
[34] L. Bonassar,et al. Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis. , 1997, Osteoarthritis and cartilage.
[35] M. Billah,et al. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.
[36] Y Wang,et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[37] R. Duncan,et al. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. , 1999, International journal of pharmaceutics.
[38] Y Ikada,et al. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. , 1997, Biomaterials.